Published in Int J Colorectal Dis on May 22, 2003
Differential angiogenic regulation of experimental colitis. Am J Pathol (2006) 1.55
Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol (2011) 1.35
Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol (2007) 1.02
Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. World J Gastroenterol (2005) 0.93
Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases. Dis Markers (2014) 0.89
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol (2010) 0.86
Expression of p53, VEGF, microvessel density, and cyclin-D1 in noncancerous tissue of inflammatory bowel disease. Dig Dis Sci (2008) 0.85
Angiogenesis in Inflammatory Bowel Disease. Int J Inflam (2015) 0.82
Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One (2013) 0.81
Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. World J Gastroenterol (2006) 0.81
Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol (2015) 0.81
Treatment of Crohn's disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study. Tech Coloproctol (2015) 0.76
Advances in the biology of cerebral cavernous malformations. Surg Neurol Int (2010) 0.75
α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology (1976) 15.65
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (1989) 4.13
Influence of platelet size on outcome after myocardial infarction. Lancet (1991) 4.12
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J (2001) 1.91
VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol (2001) 1.80
Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol (2001) 1.78
Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res (1997) 1.74
In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (1998) 1.54
VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol (2001) 1.41
Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J (1998) 1.29
Growth factors in inflammatory bowel disease. Inflamm Bowel Dis (1999) 1.29
Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology (2000) 1.23
Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol (1998) 1.17
Elevated thrombopoietin serum levels in patients with inflammatory bowel disease. Am J Gastroenterol (2000) 1.03
Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci (1999) 1.01
Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology (1999) 0.98
Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology (2002) 0.89
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res (2006) 2.68
Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys (2006) 2.34
Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration (2014) 2.10
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res (2003) 2.08
Attitudes towards mandatory vaccination and vaccination coverage against vaccine-preventable diseases among health-care workers in tertiary-care hospitals. J Infect (2011) 1.87
Evaluation of a multisensor armband in estimating energy expenditure in obese individuals. Obesity (Silver Spring) (2006) 1.85
Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. J Clin Oncol (2006) 1.74
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 1.74
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis (2005) 1.71
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia (2005) 1.62
Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res (2003) 1.60
Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol (2008) 1.58
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer (2004) 1.55
Acquired reactive perforating collagenosis: current status. J Dermatol (2010) 1.54
Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol (2003) 1.47
Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol (2008) 1.47
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin Cancer Res (2011) 1.46
The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol (2010) 1.45
Metastatic cancer cells from c-erbB-2 negative primary breast cancer maintain the original c-erbB-2/HIF1alpha phenotype. Cancer Biol Ther (2007) 1.38
Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy (2009) 1.38
LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol (2010) 1.32
The diabetic hand: a forgotten complication? J Diabetes Complications (2009) 1.32
BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res (2004) 1.31
Giant multilocular epidermoid cyst on the left buttock. Dermatol Surg (2005) 1.31
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin Cancer Res (2004) 1.30
Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest (2008) 1.30
Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer (2002) 1.27
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol (2003) 1.22
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2003) 1.20
Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther (2007) 1.18
Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol (2006) 1.17
Individual cases of autochthonous malaria in Evros Province, northern Greece: entomological aspects. Parasitol Res (2002) 1.14
Spinal metastasis of glioblastoma multiforme: an uncommon suspect? Spine (Phila Pa 1976) (2010) 1.13
"Autophagic flux" in normal mouse tissues: focus on endogenous LC3A processing. Autophagy (2011) 1.12
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy. Oncology (2009) 1.12
Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol (2010) 1.11
Aortocaval fistula formation due to ruptured abdominal aortic aneurysms: a 12-year series. Vasc Endovascular Surg (2012) 1.09
Dermoid cyst in the hepatoduodenal ligament: report of a case. Surg Today (2008) 1.08
Obstructive sleep apnea aggravates glycemic control across the continuum of glucose homeostasis. Am J Respir Crit Care Med (2010) 1.08
Clear cell sarcoma of the scapula. A case report and review of the literature. World J Surg Oncol (2006) 1.07
Individual cases of autochthonous malaria in Evros Province, northern Greece: serological aspects. Parasitol Res (2002) 1.06
Acute abdomen as initial presentation of gestational choriocarcinoma. Arch Gynecol Obstet (2009) 1.05
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci (2006) 1.05
A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect (2009) 1.05
Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol (2014) 1.05
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol (2006) 1.04
Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci (2004) 1.02
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol (2011) 1.02
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol (2008) 1.01
Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci (2006) 1.01
Metformin and cancer: licence to heal? Expert Opin Investig Drugs (2010) 1.01
Spermatic cord metastasis as an initial manifestation of sigmoid colon carcinoma: report of a case. Surg Today (2002) 1.00
Hypoxia and activated VEGF/receptor pathway in multiple myeloma. Anticancer Res (2010) 0.99
Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol (2006) 0.99
Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast. Int J Surg Pathol (2003) 0.99
High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas. Gynecol Oncol (2011) 0.99
HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood (2007) 0.99
Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res (2011) 0.99